Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ReShape Lifesciences, Inc. - Common Stock
(NQ:
RSLS
)
3.920
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ReShape Lifesciences, Inc. - Common Stock
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
January 04, 2023
Via
Benzinga
Looking Into Reshape Lifesciences's Recent Short Interest
↗
January 04, 2023
Reshape Lifesciences's (NASDAQ:RSLS) short percent of float has risen 25.0% since its last report. The company recently reported that it has 2 thousand shares sold short, which is 0.5% of all regular...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
January 04, 2023
Via
Benzinga
Why Oblong Shares Are Trading Higher By 59%; Here Are 20 Stocks Moving Premarket
↗
January 04, 2023
Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares rose 63.2% to $0.4201 in pre-market trading after dropping 8% on Tuesday. Elys Game Technology and Cloakbook were recently granted a license to...
Via
Benzinga
Reshape Lifesciences Earnings Perspective: Return On Capital Employed
↗
December 27, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
January 04, 2023
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!
Via
InvestorPlace
Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
January 03, 2023
Gainers Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
January 03, 2023
Via
Benzinga
Wall Street Starts 2023 On Positive Note
↗
January 03, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
December 30, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
December 29, 2022
Via
Benzinga
ReShape Lifesciences Announces 1-for-50 Reverse Stock Split Effective as of Commencement of Trading on December 23, 2022
December 22, 2022
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
↗
December 30, 2022
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
December 15, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
November 29, 2022
On Tuesday, 89 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
December 20, 2022
On Tuesday, 298 companies achieved new lows for the year.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
November 29, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
November 16, 2022
Via
Benzinga
ReShape Lifesciences(TM) (NASDAQ: RSLS) Featured in Coverage of Investor Summit Group’s Q4 Event
November 15, 2022
Via
Investor Brand Network
ReShape Lifesciences™ Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 14, 2022
Conference Call to be Held at 8:00 am ET Today
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Earnings Scheduled For November 14, 2022
↗
November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Via
Benzinga
ReShape Lifesciences Announces $750,000 Registered Direct Offering
November 08, 2022
From
ReShape Lifesciences Inc
Via
GlobeNewswire
ReShape Lifesciences™ to Announce Financial Results for the Third Quarter Ended September 30, 2022, and Provide Corporate Update
November 07, 2022
Conference Call to be Held at 8:00 am ET on Monday, November 14, 2022
From
ReShape Lifesciences Inc
Via
GlobeNewswire
ReShape Lifesciences™ Presents Data on Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at ObesityWeek®
November 03, 2022
Stimulation of Vagus Celiac Fibers with Concurrent High Frequency Alternating Current Block of Hepatic Fibers Decreases Glucose Variability in a Swine Model of Type 2 Diabetes
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
↗
November 04, 2022
Friday's session saw 236 companies set new 52-week lows.
Via
Benzinga
ReShape Lifesciences to Present at the Q4 Investor Summit
November 02, 2022
From
ReShape Lifesciences Inc
Via
GlobeNewswire
ReShape Lifesciences™ Announces That the ASMBS and IFSO Have Issued Updated Guidelines on Indications for Metabolic and Bariatric Surgery, Including the Lap-Band®
October 31, 2022
From
ReShape Lifesciences Inc
Via
GlobeNewswire
ReShape Lifesciences™ Announces Publication of Data on Proprietary Diabetes Bloc-Stim Neuromodulation™ (DBSN™) System in Peer Reviewed, Frontiers in NeuroScience
October 25, 2022
From
ReShape Lifesciences Inc
Via
GlobeNewswire
ReShape Lifesciences™ Announces Release of a Positive Consensus Statement on Lap-Band® Use and Lap-Band® Aftercare Management by the American Society of Metabolic and Bariatric Surgery (ASMBS)
October 20, 2022
From
ReShape Lifesciences Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
October 10, 2022
Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by 12.7% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $1.2 million.
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
